Any current/future new fundraising through debt or equity?

No major CAPEX is expected for the current financial year, implying limited immediate funding needs. (Page 10, Page 22) The management indicated significant capex was already incurred in the first phase, with minimal incremental capex expected for the second phase capacity expansion. (Page 22) On debt reduction, the company plans to reduce long-term debt by approximately INR 160 crores in FY26. (Page 10) Debt-free status is targeted for standalone operations by FY26-FY27, though consolidated debt will continue for 2 more years due to subsidiary debts. (Page 11) No explicit mention of new equit

Any current/future capex/capital investment/strategic investment?

For the multipurpose plant's second phase expansion, not much CAPEX is currently required as a good amount was spent during the first phase. Further CAPEX details will be shared once the first phase reaches full capacity utilization. No additional land is needed for the capacity expansion due to ample existing land availability. No major CAPEX is expected for the current financial year. Long-term debt reduction of around INR 160 crores is planned for FY26, indicating financial consolidation but no large new capital outlay. The focus presently is on stabilizing and optimizing the first

Future growth expectations in sales/revenue/volumes?

Overall revenue growth expected in the range of 15% to 20% for the current financial year (Page 10). Agrochemical segment revenue growth predicted between 15% to 20% (Page 20). Volume growth for Agrochemical was about 14% for the year, with Q4 volume growth lower by about 8% compared to the previous year (Page 20). Nano Urea segment shows good acceptance; field activities ongoing in 35-40 countries with expected significant growth over the next 2-3 years (Pages 8, 10). Multipurpose Plant (MPP) targeted to grow from INR 250 crores to INR 1,000 crores by FY27/FY28 (Pages 6, 20). Brazil market ex

Future growth expectations in earnings/operating earnings/profits/EPS?

Meghmani Organics expects double-digit revenue growth of around 15% to 20% for FY26, driven by core segments regaining momentum and growing Crop Nutrition segment. The company anticipates improvement in profitability with EBITDA margins sustaining in double digits across segments. Crop Protection segment is targeted to generate about 15%-16% EBITDA margin in FY26. Pigment segment (green and blue) margins expected to improve to 8%-9% EBITDA in FY26, but 15%-16% margin unlikely in near term. Multipurpose Plant (MPP) projected to achieve INR 1,000 crores revenue by FY27 or FY28, aiding revenue an

Meghmani Organics LtdQ4 FY25Fertilizers & Agrochemicals

Meghmani Organics Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹59.55P/E: 23.6Market Cap: ₹1.5K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Overall revenue growth expected in the range of 15% to 20% for the current financial year (Page 10).
Agrochemical segment revenue growth predicted between 15% to 20% (Page 20).
Volume growth for Agrochemical was about 14% for the year, with Q4 volume growth lower by about 8% compared to the previous year (Page 20).
Nano Urea segment shows good acceptance; field activities ongoing in 35-40 countries with expected significant growth over the next 2-3 years (Pages 8, 10).
Multipurpose Plant (MPP) targeted to grow from INR 250 crores to INR 1,000 crores by FY27/FY28 (Pages 6, 20).
Brazil market expected to grow at 15% to 20% year-on-year (Page 12).
New products in Agrochemical segment expected to contribute majority of growth over next 2 years (Page 14).
Double-digit volume growth expected to continue in Phthalocyanine Pigment business, though growth will be modest due to segment size (Page 16).

Margin guidance

Category 3

Meghmani Organics expects double-digit revenue growth of around 15% to 20% for FY26, driven by core segments regaining momentum and growing Crop Nutrition segment.
The company anticipates improvement in profitability with EBITDA margins sustaining in double digits across segments.
Crop Protection segment is targeted to generate about 15%-16% EBITDA margin in FY26.
Pigment segment (green and blue) margins expected to improve to 8%-9% EBITDA in FY26, but 15%-16% margin unlikely in near term.
Multipurpose Plant (MPP) projected to achieve INR 1,000 crores revenue by FY27 or FY28, aiding revenue and profit growth.
Nano Urea business EBITDA margins expected around 20%, with utilization ramping over 2-3 years.
Antidumping duty on TiO2 may positively impact margins and overall bottom line from next quarter onwards.
Overall, management is optimistic about top-line and bottom-line growth, with FY25 showing strong turnaround and positive EBIT and PAT.

See what Meghmani Organics Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

No major CAPEX is expected for the current financial year, implying limited immediate funding needs. (Page 10, Page 22)
The management indicated significant capex was already incurred in the first phase, with minimal incremental capex expected for the second phase capacity expansion. (Page 22)
On debt reduction, the company plans to reduce long-term debt by approximately INR 160 crores in FY26. (Page 10)
Debt-free status is targeted for standalone operations by FY26-FY27, though consolidated debt will continue for 2 more years due to subsidiary debts. (Page 11)
No explicit mention of new equity fundraising was made during the call.
Overall, the company seems focused on utilizing internal accruals and existing resources rather than raising fresh debt or equity in near term.

Order book

The provided transcript and document do not contain specific information on Meghmani Organics Limited's current or expected order book or pending orders. The discussion primarily focuses on: - EBITDA margins and segment profitability for Pigment and Agrochemical segments. - Revenue growth and capacity utilization, including the multipurpose plant (MPP). - Pricing pressures and market demand. - Expectations for revenue growth (15%-20%) in Agrochemical segment. - Outlook on margins considering market dynamics and competition. No explicit details or figures regarding the order book or pending orders are mentioned in the transcript. For precise order book status, direct company disclosures or investor reports would need to be consulted.

See what Meghmani Organics Ltd management said on order book — free account, 30 seconds.

Capex plans

For the multipurpose plant's second phase expansion, not much CAPEX is currently required as a good amount was spent during the first phase. Further CAPEX details will be shared once the first phase reaches full capacity utilization.
No additional land is needed for the capacity expansion due to ample existing land availability.
No major CAPEX is expected for the current financial year.
Long-term debt reduction of around INR 160 crores is planned for FY26, indicating financial consolidation but no large new capital outlay.
The focus presently is on stabilizing and optimizing the first phase of the multipurpose plant before advancing further expansion or capital investment.

Track Meghmani Organics Ltd — get its next earnings analysis in your feed

How does Meghmani Organics Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisMeghmani Organics Ltd

Rev 3Mar 3

See where Meghmani Organics Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Meghmani Organics Ltd rank in Fertilizers & Agrochemicals?

Compare Meghmani Organics Ltd against every Fertilizers & Agrochemicals company (Q4 FY25) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Meghmani Organics Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Bhagiradha Chemicals & Industries Ltd (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
Bhagiradha Chemicals & Industries Ltd (Q3 FY26)
114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran
Advance Agrolife Ltd (Q3 FY26)
Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways
Dhansa Labs Ltd (Q4 FY26)
120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs Sumitomo Chemical India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Meghmani Organics Ltd Q4 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Meghmani Organics Ltd rank in Fertilizers & Agrochemicals?

Continue your research

What Meghmani Organics Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season